Exploring how delayed feedback affects learning in Parkinson's Disease
Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease
Kessler Foundation · NCT06217484
This study is testing if giving feedback after a delay can help people with Parkinson's Disease learn better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 55 Years and up |
| Sex | All |
| Sponsor | Kessler Foundation (other) |
| Locations | 1 site (East Hanover, New Jersey) |
| Trial ID | NCT06217484 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the impact of delayed feedback on learning deficits in individuals with Parkinson's Disease. Participants will complete a multiple-choice test and receive feedback either immediately or after a 25-minute delay. The study aims to determine if delayed feedback can enhance learning outcomes, as it does not rely on dopamine, which is disrupted in Parkinson's patients. By understanding the effects of feedback timing, the research seeks to improve learning strategies for those affected by this condition.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Parkinson's Disease who have a Montreal Cognitive Assessment score above 24.
Not a fit: Patients with other neurological conditions or those with significant cognitive impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance learning and cognitive function in patients with Parkinson's Disease.
How similar studies have performed: While the specific approach of delayed feedback in Parkinson's Disease is novel, similar studies have shown that feedback mechanisms can influence learning in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Only participants with scores above 24/30 on the Montreal Cognitive Assessment will be recruited for participation to exclude dementia. Exclusion Criteria: * Individuals with neurological conditions other than PD such as epilepsy, multiple sclerosis, brain tumors, etc. will be excluded to control for the effects these conditions have on the brain and behavior.
Where this trial is running
East Hanover, New Jersey
- Kessler Foundation — East Hanover, New Jersey, United States (RECRUITING)
Study contacts
- Principal investigator: Ekaterina Dobryakova, PhD — Kessler Foundation
- Study coordinator: Kai Sucich, MA
- Email: ksucich@kesslerfoundation.org
- Phone: 973-323-3693
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Parkinson Disease, learning, feedback